HEXO Corp. - stock earnings
Stock symbol HEXO is outdated, potentially delisted? Maybe it is available on other exchange?
HEXO Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023Q2 | -117.2 million CAD | 21.6 million CAD |
| 2023Q1 | 722000 CAD | 24.2 million CAD |
| 2022Q4 | -56.3 million CAD | 35.8 million CAD |
| 2022Q3 | -100.4 million CAD | 42.6 million CAD |
| 2022Q2 | -145.0 million CAD | 45.6 million CAD |
| 2022Q1 | -710.9 million CAD | 52.8 million CAD |
| 2021Q4 | -117.3 million CAD | 50.2 million CAD |
| 2021Q3 | -69.0 million CAD | 38.8 million CAD |
| 2021Q2 | -20.7 million CAD | 22.7 million CAD |
HEXO Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2022 | -1.1 billion CAD | 191.1 million CAD |
| 2021 | -114.8 million CAD | 123.8 million CAD |
| 2020 | -546.5 million CAD | 80.8 million CAD |
| 2019 | -69.6 million CAD | 47.5 million CAD |
| 2018 | -23.4 million CAD | 4.9 million CAD |
HEXO
Price: $0.71
52 week price:
Earnings Per Share: -0.39 USD
P/E Ratio: -0.54
Exchange: NCM
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Volume: 3.7 million
Market Capitalization: 66.0 million